The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback